Recruiting A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer NCT07459751 Conditions Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Locations Cancer Hospital, Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China View Trial Details
Recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827 Conditions Advanced Cutaneous Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +21 more Locations GenesisCare North Shore — Sydney, New South Wales, Australia Westmead Hospital — Westmead, New South Wales, Australia ICON Cancer Centre South Brisbane — Brisbane, Queensland, Australia Greenslopes Private Hospital — Greenslopes, Queensland, Australia View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
